Cargando…
Artificial Intelligence in Paediatric Tuberculosis
Tuberculosis (TB) continues to be a leading cause of death in children despite global efforts focused on early diagnosis and interventions to limit the spread of the disease. This challenge has been made more complex in the context of the coronavirus pandemic, which has disrupted the “End TB Strateg...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883137/ https://www.ncbi.nlm.nih.gov/pubmed/36707428 http://dx.doi.org/10.1007/s00247-023-05606-9 |
_version_ | 1784879441975967744 |
---|---|
author | Naidoo, Jaishree Shelmerdine, Susan Cheng -Charcape, Carlos F. Ugas Sodhi, Arhanjit Singh |
author_facet | Naidoo, Jaishree Shelmerdine, Susan Cheng -Charcape, Carlos F. Ugas Sodhi, Arhanjit Singh |
author_sort | Naidoo, Jaishree |
collection | PubMed |
description | Tuberculosis (TB) continues to be a leading cause of death in children despite global efforts focused on early diagnosis and interventions to limit the spread of the disease. This challenge has been made more complex in the context of the coronavirus pandemic, which has disrupted the “End TB Strategy” and framework set out by the World Health Organization (WHO). Since the inception of artificial intelligence (AI) more than 60 years ago, the interest in AI has risen and more recently we have seen the emergence of multiple real-world applications, many of which relate to medical imaging. Nonetheless, real-world AI applications and clinical studies are limited in the niche area of paediatric imaging. This review article will focus on how AI, or more specifically deep learning, can be applied to TB diagnosis and management in children. We describe how deep learning can be utilised in chest imaging to provide computer-assisted diagnosis to augment workflow and screening efforts. We also review examples of recent AI applications for TB screening in resource constrained environments and we explore some of the challenges and the future directions of AI in paediatric TB. |
format | Online Article Text |
id | pubmed-9883137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-98831372023-01-30 Artificial Intelligence in Paediatric Tuberculosis Naidoo, Jaishree Shelmerdine, Susan Cheng -Charcape, Carlos F. Ugas Sodhi, Arhanjit Singh Pediatr Radiol Tuberculosis Minisymposium Tuberculosis (TB) continues to be a leading cause of death in children despite global efforts focused on early diagnosis and interventions to limit the spread of the disease. This challenge has been made more complex in the context of the coronavirus pandemic, which has disrupted the “End TB Strategy” and framework set out by the World Health Organization (WHO). Since the inception of artificial intelligence (AI) more than 60 years ago, the interest in AI has risen and more recently we have seen the emergence of multiple real-world applications, many of which relate to medical imaging. Nonetheless, real-world AI applications and clinical studies are limited in the niche area of paediatric imaging. This review article will focus on how AI, or more specifically deep learning, can be applied to TB diagnosis and management in children. We describe how deep learning can be utilised in chest imaging to provide computer-assisted diagnosis to augment workflow and screening efforts. We also review examples of recent AI applications for TB screening in resource constrained environments and we explore some of the challenges and the future directions of AI in paediatric TB. Springer Berlin Heidelberg 2023-01-28 /pmc/articles/PMC9883137/ /pubmed/36707428 http://dx.doi.org/10.1007/s00247-023-05606-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Tuberculosis Minisymposium Naidoo, Jaishree Shelmerdine, Susan Cheng -Charcape, Carlos F. Ugas Sodhi, Arhanjit Singh Artificial Intelligence in Paediatric Tuberculosis |
title | Artificial Intelligence in Paediatric Tuberculosis |
title_full | Artificial Intelligence in Paediatric Tuberculosis |
title_fullStr | Artificial Intelligence in Paediatric Tuberculosis |
title_full_unstemmed | Artificial Intelligence in Paediatric Tuberculosis |
title_short | Artificial Intelligence in Paediatric Tuberculosis |
title_sort | artificial intelligence in paediatric tuberculosis |
topic | Tuberculosis Minisymposium |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883137/ https://www.ncbi.nlm.nih.gov/pubmed/36707428 http://dx.doi.org/10.1007/s00247-023-05606-9 |
work_keys_str_mv | AT naidoojaishree artificialintelligenceinpaediatrictuberculosis AT shelmerdinesusancheng artificialintelligenceinpaediatrictuberculosis AT charcapecarlosfugas artificialintelligenceinpaediatrictuberculosis AT sodhiarhanjitsingh artificialintelligenceinpaediatrictuberculosis |